Showing 1 - 1 results of 1 for search 'Ravi Chari', query time: 0.01s Refine Results
  1. 1
    A bispecific anti-MUC16/anti-death receptor 5 antibody achieves effective and tumor-selective death receptor 5-mediated tumor regression

    A bispecific anti-MUC16/anti-death receptor 5 antibody achieves effective and tumor-selective death receptor 5-mediated tumor regression by Victor S. Goldmacher, Iosif Gershteyn, Ravi Chari, Yelena Kovtun

    Published 2025-03-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: